Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
European Journal of Heart Failure|March 14, 2001
Isolated diastolic heart failure as a cause of breathlessness in the community: the Arbroath studyR J MacFadyen, C M MacLeod, P Shiels, et al.Antimicrobial Agents and Chemotherapy|April 1, 1986
Aztreonam penetration into synovial fluid and boneC M MacLeod, E A Bartley, J O Galante, et al.The Journal of Experimental Medicine|October 30, 2009
ANTIBODY FORMATION IN MEN FOLLOWING INJECTION OF FOUR TYPE-SPECIFIC POLYSACCHARIDES OF PNEUMOCOCCUSM Heidelberger, C M Macleod, R G Hodges, et al.Journal of Clinical Pharmacology|November 1, 1986
Protein-bound homocyst(e)ine in patients with rheumatoid arthritis undergoing D-penicillamine treatmentS S Kang, P W Wong, P B Glickman, et al.Antimicrobial Agents and Chemotherapy|October 1, 1984
Effects of cirrhosis on kinetics of aztreonamC M MacLeod, E A Bartley, J A Payne, et al.Neurology|May 1, 1993
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exerciseC G Goetz, J A Thelen, C M MacLeod, et al.Biopharmaceutics & Drug Disposition|May 1, 1989
Single oral dose proportionality pharmacokinetics of almitrine bismesylate in humansS Stavchansky, J T Doluisio, C M Macleod, et al.Biopharmaceutics & Drug Disposition|May 1, 1989
Relative bioavailability of almitrine bismesylate in humansS Stavchansky, J T Doluisio, C M Macleod, et al.Biopharmaceutics & Drug Disposition|May 1, 1989
One year administration of almitrine bismesylate (Vectarion) to chronic obstructive pulmonary disease patients: pharmacokinetic analysisS Stavchansky, J T Doluisio, C M Macleod, et al.Scottish Medical Journal|December 1, 1995
Psychosis and substance abuse: cause, effect or coincidence?S M Lawrie, J K Hutchison, S R Sweeney, et al.Pageof 8